tiprankstipranks
NOXXON Pharma NV (DE:0N6A)
:0N6A
Germany Market
Holding DE:0N6A?
Track your performance easily

NOXXON Pharma NV (0N6A) Income Statement

0 Followers

NOXXON Pharma NV Income Statement

Last quarter (Q2 2022), NOXXON Pharma NV's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, NOXXON Pharma NV's net income was $―. See NOXXON Pharma NV’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ ―$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
$ ―$ ―$ ―$ 1.03M$ 982.00K$ 959.00K
Gross Profit
$ ―$ ―$ ―$ -1.03M$ -982.00K$ -959.00K
Operating Expense
$ ―$ 13.45M$ 5.78M$ 2.92M$ 3.34M$ 3.77M
Operating Income
$ ―$ -13.45M$ -5.78M$ -3.94M$ -4.32M$ -4.73M
Net Non Operating Interest Income Expense
$ ―$ -1.19M$ -4.64M$ 3.09M$ -6.37M$ -659.00K
Other Income Expense
$ ―$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ -14.45M$ -10.41M$ -860.00K$ -10.74M$ -5.39M
Tax Provision
$ ―$ 1.00K$ 0.00$ 1.00K$ 1.00K$ 1.00K
Earnings From Equity Interest Net Of Tax
$ ―$ ―$ ―$ ―$ ―$ ―
Net Income Common Stockholders
$ ―$ -14.45M$ -10.40M$ -861.00K$ -10.73M$ -5.38M
Basic EPS
$ ―$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―$ ―
Basic Average Shares
$ ―$ ―$ ―$ ―$ ―$ ―
Diluted Average Shares
$ ―$ ―$ ―$ ―$ ―$ ―
Dividend Per Share
$ ―$ ―$ ―$ ―$ ―$ ―
Total Operating Income As Reported
$ ―$ ―$ ―$ ―$ ―$ ―
Reported Normalized Basic E P S
$ ―$ ―$ ―$ ―$ ―$ ―
Reported Normalized Diluted E P S
$ ―$ ―$ ―$ ―$ ―$ ―
Rent Expense Supplemental
$ ―$ ―$ ―$ ―$ ―$ 51.00K
Total Expenses
$ ―$ 13.45M$ 5.78M$ 3.94M$ 4.32M$ 4.73M
Net Income From Continuing And Discontinued Operation
$ ―$ -14.45M$ -10.40M$ -861.00K$ -10.73M$ -5.38M
Normalized Income
$ ―$ -14.45M$ -10.40M$ -861.00K$ -10.73M$ -5.38M
Interest Expense
$ ―$ 1.50M$ 5.05M$ 3.00K$ 6.76M$ 1.68M
EBIT
$ ―$ -12.95M$ -5.35M$ -857.00K$ -3.98M$ -3.71M
EBITDA
$ ―$ -12.88M$ -5.29M$ -810.00K$ -3.96M$ -3.68M
Currency in USD

NOXXON Pharma NV Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis